[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100515293":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":11,"centralContacts":15,"locations":24,"responsibleParty":43,"collaborators":45,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":94,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":110},{"fullName":5,"class":6},"Virginia Commonwealth University","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"LGMD, DM2, LOPD",null,[12],{"name":13,"affiliation":5,"role":14},"Nicholas Johnson, MD","PRINCIPAL_INVESTIGATOR",[16,21],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Jennifer Raymond","CONTACT","804-828-6318","Jennifer.Raymond@vcuhealth.org",{"name":22,"role":18,"phone":10,"phoneExt":10,"email":23},"Ruby Langeslay","Ruby.Langeslay@vcuhealth.org",[25],{"facility":5,"status":26,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"RECRUITING","Richmond","Virginia","23298","United States","US",{"type":33,"coordinates":34},"Point",[35,36],-77.46026,37.55376,{"lat":36,"lon":35},[39,42],{"name":40,"role":18,"phone":10,"phoneExt":10,"email":41},"Levi Headrick","levi.headrick@vcuhealth.org",{"name":13,"role":14,"phone":10,"phoneExt":10,"email":10},{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[46],{"name":47,"class":6},"Muscular Dystrophy Association","100515293","long-term-development-of-muscular-dystrophy-outcome-assessments-100515293",false,"NCT05989620","Long-Term Development of Muscular Dystrophy Outcome Assessments","Long-Term Development of Muscular Dystrophy Outcome Assessments (GRASP-01-005)","GRASP-01-005","Inclusion Criteria:\n\n1. Age between 6-50 years at enrollment\n2. Clinically affected (defined as weakness on bedside evaluation in a pattern consistent with proximal weakness)\n3. Genetic confirmation of a LGMD, DM2, or LOPD\n4. FVC above 30% of predicted\n\nExclusion Criteria:\n\n1. Any other illness that would interfere with the ability to undergo safe testing or would interfere with interpretation of the results in the opinion of the site investigator\n2. Participation in a clinical trial receiving an investigational product","ALL","6 Years","50 Years",{"count":60,"type":61},1000,"ESTIMATED","OBSERVATIONAL","This is a 24-month, observational study of up to 1000 participants with Limb Girdle Muscular Dystrophy (LGMD), Myotonic Dystrophy Type 2 (DM2), and late onset Pompe disease (LOPD).",[65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93],"LGMD1B","LGMD1C","LGMD1D","LGMD1E","LGMD1F","LGMD1G","LGMD1H","LGMD2A","LGMD2B","LGMD2C","LGMD2D","LGMD2E","LGMD2F","LGMD2G","LGMD2I","LGMD2J","LGMD2K","LGMD2L","LGMD2M","LGMD2N","LGMD2O","LGMD2P","LGMD2Q","LGMD2S","LGMD2T","LGMD2U","LGMD2W","LGMD2X","LGMD2Y",[95,96,97,98,99,100],"Muscular Dystrophy","Myotonic Dystrophy","Limb Girdle Muscular Dystrophy","LGMD","LOPD","Late Onset Pompe Disease","2025-11-17",{"date":103,"type":104},"2025-11-18","ACTUAL",{"date":106,"type":104},"2023-10-18",{"date":108,"type":61},"2029-05-01",{"name":5,"class":6},1]